Behavioural anxiolytic effects of low-dose anabolic androgenic steroid treatment in rats.
The use of anabolic androgenic steroids (AAS) in supratherapeutic doses has been associated with aggressive behaviour as well as with severe affective and psychotic symptoms. These symptoms usually follow a chronic exposure for several months. However, AAS also may have milder effects with hypomania-like features such as an increase in confidence, energy and self-esteem. We have studied the short-term effects on male rat behaviour in a modified open-field test of the AAS Metenolon administered three times at a low dose (0.01 mg/kg/week x 3). The control rats showed indications of increased timidity and aversive learning following retesting, a reaction that was absent in the AAS-treated rats. The AAS-treated rats showed less fear or anticipatory anxiety compared to control animals. Furthermore, the suppressed marking behaviour and altered morphological allometric relationships were compatible with a modified social and sexual competence in the AAS treated rats.
Agren
G
G
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. greta.agren@fyfa.ki.se
Thiblin
I
I
Tirassa
P
P
Lundeberg
T
T
Stenfors
C
C
D000378:Agonistic Behavior / Q000187:drug effects; D045930:Anabolic Agents / Q000494:pharmacology*; D000818:Animals; D001007:Anxiety / Q000188:drug therapy*; D001362:Avoidance Learning / Q000187:drug effects*; D016009:Chi-Square Distribution; D004334:Drug Administration Schedule; D005106:Exploratory Behavior / Q000187:drug effects*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013223:Statistics as Topic; D013731:Territoriality
D045930:Anabolic Agents